Clinical Trials Logo

Uterine Prolapse clinical trials

View clinical trials related to Uterine Prolapse.

Filter by:

NCT ID: NCT00827528 Completed - Clinical trials for Pelvic Organ Prolapse

SIS Graft and Traditional Repair in Vaginal Wall Prolapse

Start date: August 2006
Phase: Phase 4
Study type: Interventional

The objective of this study is to evaluate surgical treatment of anterior vaginal wall prolapse using the sis graft or traditional repair. This a randomized and prospective study. Clinical patterns that will be evaluated: anatomic results of surgery; impact of surgery in quality of life using the Pelvic Organ Prolapse Questionnaire (P-QoL), sexual function with FSFI and possible complications.

NCT ID: NCT00679276 Completed - Vaginal Prolapse Clinical Trials

Treatment Outcomes of Vaginal Prolapse Repair

Start date: May 2008
Phase: N/A
Study type: Observational

Chart review conducted on all patients having had Prolift surgery since 2005 by Dr. Lary Sirls, Dr. Predeep Nagaraju and Dr. Kenneth Peters at William Beaumont Hospital.

NCT ID: NCT00564083 Completed - Uterine Prolapse Clinical Trials

Randomized Controlled Trial Comparing Acellular Collagen Biomesh (Pelvisoft) to Polypropylene Mesh(Pelvitex) for Sacral Colpopexy

Start date: December 2005
Phase: N/A
Study type: Interventional

This research protocol is a randomized controlled trial. It is being done to compare and find out the relative differences between the materials, (Pelivisoft) "natural organic mesh" to poly propylene mesh (Pelvitex) "manmade mesh" after a surgery known as sacral colpopexy. This surgery involves supporting the prolapsed vaginal wall with a piece of material (known as a graft) attached to a ligament along your backbone (or sacrum). These materials are both FDA approved and widely used. The following objectives: anatomic outcomes, graft-related complications between the two materials, changes in pelvic organ prolapse-related quality of life, subjective changes in sexual function,changes in bowel function and the prolapse related pain present after sacral colpopexy will be evaluated. The study visits are all under standard of care. Study questionnaires are unique to the study and will be completed at the enrollment in hospital, 2, 6,12 weeks, 6 months and one year visits The questionnaires are related to bowel function, bladder function, prolapse and sexual activity. Permission will be requested to contact the patient again 5 years after surgery. Contact in the future will in no way obligate the patient to participate. There may or may not be direct medical benefits to the participant. Decreased risk of erosion may be a possible benefit if placed in the organic "natural" arm of the study. The information learned from this study may benefit other patients in the future

NCT ID: NCT00564044 Active, not recruiting - Clinical trials for Urinary Incontinence

The Immune Reactivity of Biofilms in Vaginal Mesh Erosion.

Start date: August 2007
Phase: N/A
Study type: Interventional

Aging, birth trauma and extensive pelvic surgery are the causes known to cause advanced pelvic organ prolaspe, fecal as well as urinary incontinence. Surgical treatment is the last resort to manage the above-mentioned clinical manifestations of pelvic floor disorders except the subject is too frail to receive operation. In order to improve the outcome of reconstructive pelvic surgery, reinforcement with synthetic mesh or biological material is the modern trend in pelvic repair. Unfortunately no prosthesis including synthetic or biological is ideal because vaginal erosion with mesh extrusion which is the subject of this protocol and other complications were reported continuously. As per the literature, the rate for mesh vaginal extrusion ranged between 2.4 and 17% when polypropylene which is the most popular synthetic material used for the mid-urethral sling or pelvic reconstructive surgery to date. The causes of this complication are still controversial which include rejection, poor quality of tissue, surgical artifact, material of mesh and etc. A prospective controlled study for the investigation of the cause for mesh vaginal erosion was conducted and the results revealed evidences of immune reactivity after mesh implantation, albeit the evidence was not solid (Am J Obstet Gynecol 2004; 191(6): 1868-1874 ). As per the pilot study initially done by us to determine the biofilm-related-infection, we have found bacterial biofilm could adhere to surfaces and interfaces, i.e. bacteria located in the cells just beneath the contacting surfaces in the electron microscopic (EM) analysis. In addition, soon after bacteria infection, proteins in biofilm undergo conformational changes, making them immunogenic and triggers a typical inflammatory response leading to activation of the complement system. Thus, we plan to use CD (clusters of differentiation) antigens - 4, 8, 20, 25, 40, 68 and quantitative analysis of FoxP3 to determine the function of regulatory T cells in the immune response. In addition, bacterial culture and EM analysis of the excised mesh with surrounding vagina tissue will be performed for further analysis of biofilms.

NCT ID: NCT00557882 Completed - Clinical trials for Pelvic Organ Prolapse

Efficacy Study of Vaginal Mesh for Anterior Prolapse

VAMP-A
Start date: June 2007
Phase: Phase 4
Study type: Interventional

The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for anterior prolapse compared to traditional vaginal reconstructive surgery without mesh.

NCT ID: NCT00535301 Completed - Clinical trials for Urinary Incontinence

Outcomes of Anterior Colporrhaphy Versus Graft Reinforced Anterior Prolapse Repair

Start date: January 2005
Phase: Phase 4
Study type: Interventional

The purpose of this study is determine whether grafted anterior vaginal prolapse repair is more effective and associated with less complications than prolapse repair with suture.

NCT ID: NCT00475540 Completed - Clinical trials for Pelvic Organ Prolapse

Efficacy Study of Vaginal Mesh for Prolapse

VAMP
Start date: January 2007
Phase: N/A
Study type: Interventional

The primary aim of this double-blind, randomized clinical trial (RCT) is to test the hypothesis that the addition of a standardized technique of interpositional synthetic polypropylene mesh placement improves the one-year outcome of vaginal reconstructive surgery for pelvic organ prolapse compared to traditional vaginal reconstructive surgery without mesh.

NCT ID: NCT00460434 Completed - Clinical trials for Pelvic Organ Prolapse

Outcomes Following Vaginal Prolapse Repair and Mid Urethral Sling Trial

OPUS
Start date: May 2007
Phase: Phase 2
Study type: Interventional

Pelvic organ prolapse is common among women with a prevalence that has been estimated to be as high as 30%. Prolapse may be corrected by surgery using either a vaginal or abdominal incision. Some women develop stress urinary incontinence (SUI) after surgery. A prior randomized trial has shown that use of a Burch sling at the time of an abdominal sacrocolpopexy decreases the risk of urinary incontinence; however, the benefit of adding an anti incontinence procedure to prevent SUI at the time of prolapse surgery performed via a vaginal approach is unclear. Thus, the objective of the Outcomes following vaginal Prolapse repair and mid Urethral Sling (OPUS) trial is to determine whether prophylactic treatment with Tension-free Vaginal Tape (TVT)® at the time of prolapse surgery done via a vaginal approach is effective in preventing urinary incontinence.

NCT ID: NCT00442247 Active, not recruiting - Vaginal Prolapse Clinical Trials

A Randomised, Controlled Study of Bimesh, Pelvicol for Vaginal Wall Prolapse

Start date: September 2004
Phase: N/A
Study type: Interventional

Anterior vaginal wall prolapse is a common problem. Until now many different surgical techniques have been evaluated but so far recurrence is often still observed. Therefore, synthetic mesh or biomesh for vaginal prolapse reconstruction have been introduced.

NCT ID: NCT00420225 Completed - Clinical trials for Anterior Vaginal Wall Prolapse

Mesh Repair of Anterior Vaginal Wall Prolapse

Start date: April 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether reenforcement with polypropylen mesh compared with traditional anterior colporrhaphy for anterior vaginal wall prolapse results in fewer recurrences.